Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Sampson

Showing results (381-390 of 393) with videos related to

Pageof 40
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiformeDavid A Reardon, Merrill J Egorin, Jennifer A Quinn, et al.
Nature Medicine|August 15, 2018
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumorsPakawat Chongsathidkiet, Christina Jackson, Shohei Koyama, et al.
Allergy|January 7, 2017
Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysisU Nurmatov, S Dhami, S Arasi, et al.
Nature Medicine|January 24, 2019
Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumorsPakawat Chongsathidkiet, Christina Jackson, Shohei Koyama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2021
Designing Clinical Trials for Combination Immunotherapy: A Framework for GlioblastomaKirit Singh, Kristen A Batich, Patrick Y Wen, et al.
Nature Cancer|June 12, 2025
A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trialEric M Thompson, David M Ashley, Katayoun Ayasoufi, et al.
Nature Reviews. Clinical Oncology|February 9, 2019
Challenges to curing primary brain tumoursKenneth Aldape, Kevin M Brindle, Louis Chesler, et al.
Nature Reviews. Clinical Oncology|June 1, 2019
Reply to 'Assembling the brain trust: the multidisciplinary imperative in neuro-oncology'Kenneth Aldape, Kevin M Brindle, Louis Chesler, et al.
Nature Communications|January 14, 2021
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapyMatthias Gromeier, Michael C Brown, Gao Zhang, et al.
Cancer Research|May 2, 2019
MTAP Loss Promotes Stemness in Glioblastoma and Confers Unique Susceptibility to Purine StarvationLandon J Hansen, Ran Sun, Rui Yang, et al.
Pageof 40

Showing results (381-390 of 393) with videos related to

Sort By:
Pageof 40
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiformeDavid A Reardon, Merrill J Egorin, Jennifer A Quinn, et al.
Nature Medicine|August 15, 2018
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumorsPakawat Chongsathidkiet, Christina Jackson, Shohei Koyama, et al.
Allergy|January 7, 2017
Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysisU Nurmatov, S Dhami, S Arasi, et al.
Nature Medicine|January 24, 2019
Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumorsPakawat Chongsathidkiet, Christina Jackson, Shohei Koyama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2021
Designing Clinical Trials for Combination Immunotherapy: A Framework for GlioblastomaKirit Singh, Kristen A Batich, Patrick Y Wen, et al.
Nature Cancer|June 12, 2025
A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trialEric M Thompson, David M Ashley, Katayoun Ayasoufi, et al.
Nature Reviews. Clinical Oncology|February 9, 2019
Challenges to curing primary brain tumoursKenneth Aldape, Kevin M Brindle, Louis Chesler, et al.
Nature Reviews. Clinical Oncology|June 1, 2019
Reply to 'Assembling the brain trust: the multidisciplinary imperative in neuro-oncology'Kenneth Aldape, Kevin M Brindle, Louis Chesler, et al.
Nature Communications|January 14, 2021
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapyMatthias Gromeier, Michael C Brown, Gao Zhang, et al.
Cancer Research|May 2, 2019
MTAP Loss Promotes Stemness in Glioblastoma and Confers Unique Susceptibility to Purine StarvationLandon J Hansen, Ran Sun, Rui Yang, et al.
Pageof 40